Steady On For US FDA’s Novel Approvals At Mid-Year, But Another 2023 Is Unlikely
Executive Summary
US FDA would need to approve 44 novel agents by year-end to match 2023’s big total, but only 40 candidates are known to have user fee goals in the second half of 2024.